Terms: = Prostate cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Staging
76 results:
1. Comparison of 68Ga-PSMA-HBED-CC and 18F-FDG PET/CT in the Evaluation of Adenoid Cystic Carcinoma-A Prospective Study.
Shamim SA; Kumar N; Arora G; Kumar D; Pathak A; Thakkar A; Sikka K; Singh CA; Kakkar A; Bhalla AS
Clin Nucl Med; 2023 Nov; 48(11):e509-e515. PubMed ID: 37812520
[TBL] [Abstract] [Full Text] [Related]
2. Treatment of primary cancer in metastatic hormone-sensitive prostate cancer.
Lim KY; Alberto M; Ranasinghe W
Curr Opin Support Palliat Care; 2023 Dec; 17(4):315-323. PubMed ID: 37788147
[TBL] [Abstract] [Full Text] [Related]
3. The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting.
Barletta F; Ceci F; van den Bergh RCN; Rajwa P; Montorsi F; Briganti A; Gandaglia G;
Curr Opin Urol; 2023 Nov; 33(6):502-509. PubMed ID: 37530704
[TBL] [Abstract] [Full Text] [Related]
4. Quantitative MRI in the Local staging of prostate cancer: A Systematic Review and Meta-Analysis.
Xiao VG; Kresnanto J; Moses DA; Pather N
J Magn Reson Imaging; 2024 Jan; 59(1):255-296. PubMed ID: 37165923
[TBL] [Abstract] [Full Text] [Related]
5. Customized Denonvilliers' Fascia Excision: An Advanced Total Mesorectal Excision Technique for Anteriorly Located Rectal cancer.
Bae SU; Varela C; Nassr M; Kim NK
Dis Colon Rectum; 2023 Jun; 66(6):e304-e309. PubMed ID: 36825985
[TBL] [Abstract] [Full Text] [Related]
6. Advanced imaging and theranostics in thyroid cancer.
Roseland ME; Dewaraja YK; Wong KK
Curr Opin Endocrinol Diabetes Obes; 2022 Oct; 29(5):456-465. PubMed ID: 36068937
[TBL] [Abstract] [Full Text] [Related]
7. Indeterminate skeletal and lymph node lesion on 18F PSMA 1007 PET/CT scanning: lessons from a review at 12 months with PSMA-RADS.
Bhoil A; Seshadri N; Vinjamuri S
Nucl Med Commun; 2022 Sep; 43(9):1034-1041. PubMed ID: 35833288
[TBL] [Abstract] [Full Text] [Related]
8. The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more?
Mei R; Farolfi A; Morigi JJ; Fanti S
Curr Opin Urol; 2022 May; 32(3):269-276. PubMed ID: 35552308
[TBL] [Abstract] [Full Text] [Related]
9. Primary urethral carcinoma: Results from a single center experience.
Calderón Cortez JF; Territo A; Fontana M; Gaya JM; Sanguedolce F; Palou J; Huguet J; Breda A
Actas Urol Esp (Engl Ed); 2022 Mar; 46(2):70-77. PubMed ID: 35120853
[TBL] [Abstract] [Full Text] [Related]
10. The Emerging Role of Next-Generation Imaging in prostate cancer.
Murthy V; Aggarwal R; Koo PJ
Curr Oncol Rep; 2022 Jan; 24(1):33-42. PubMed ID: 35059998
[TBL] [Abstract] [Full Text] [Related]
11. Applications of artificial intelligence in prostate cancer imaging.
Baltzer PAT; Clauser P
Curr Opin Urol; 2021 Jul; 31(4):416-423. PubMed ID: 33965983
[TBL] [Abstract] [Full Text] [Related]
12. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract] [Full Text] [Related]
13. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
Malik AT; Alexander J; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
[TBL] [Abstract] [Full Text] [Related]
14. PET imaging in urology: a rapidly growing successful collaboration.
Farolfi A; Koschel S; Murphy DG; Fanti S
Curr Opin Urol; 2020 Sep; 30(5):623-627. PubMed ID: 32701721
[TBL] [Abstract] [Full Text] [Related]
15. prostate-specific membrane antigen PET/computed tomography for staging prostate cancer.
Ravi Kumar AS; Lawrentschuk N; Hofman MS
Curr Opin Urol; 2020 Sep; 30(5):628-634. PubMed ID: 32701720
[TBL] [Abstract] [Full Text] [Related]
16. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder cancer.
Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
[TBL] [Abstract] [Full Text] [Related]
17. Promise of PET imaging in prostate cancer: improvement or waste of money?
Morigi JJ; Anderson J; Fanti S
Curr Opin Urol; 2020 Jan; 30(1):9-16. PubMed ID: 31652164
[TBL] [Abstract] [Full Text] [Related]
18. Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?
Pozzessere C; Bassanelli M; Ceribelli A; Rasul S; Li S; Prior JO; Cicone F
Curr Urol Rep; 2019 Oct; 20(11):68. PubMed ID: 31605269
[TBL] [Abstract] [Full Text] [Related]
19. The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer.
Koschel S; Murphy DG; Hofman MS; Wong LM
Curr Opin Urol; 2019 Nov; 29(6):569-577. PubMed ID: 31567440
[TBL] [Abstract] [Full Text] [Related]
20. The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant prostate cancer (csPCa).
Patel P; Wang S; Siddiqui MM
Curr Urol Rep; 2019 Sep; 20(10):60. PubMed ID: 31478113
[TBL] [Abstract] [Full Text] [Related]
[Next]
